Search Results 681-690 of 11525 for procedureare

  1. Change in Permeability of the Small Intestine after Treatment - Mayo Clinic

    About this study. The overall hypothesis of this research study is that gluten intake alters intestinal barrier function in patients with Irritable Bowel ...

  2. Development of Technologies to Increase In-Seat Movement to Prevent Sitting- Acquired Pressure Injuries in Wheelchair Users - Mayo Clinic

    The purpose of this study is to provide wheelchair users with personal-use technology that provides effective feedback to increase movement to prevent pressure ...

  3. Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  4. Impact of Endogenous E2 on SSI and GH Rebound - Mayo Clinic

    About this study. Endogenous estrogens maintain growth hormone (GH) secretion in postmenopausal women by potentiating endogenous GH-releasing hormone (GHRH) ...

  5. A Comparative Effectiveness Study of Major Glycemia-lowering Medications for Treatment of Type 2 Diabetes - Mayo Clinic

    About this study. The GRADE Study is a pragmatic, unmasked clinical trial that will compare commonly used diabetes medications, when combined with metformin ...

  6. A Study of the Structural Parts of Bone in Related Diseases that Have Increased Risk of Fractures - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. DS-8201a in Human Epidermal Growth Factor Receptor2 (HER2)-Expressing Colorectal Cancer (DESTINY-CRC01) - Mayo Clinic

    The main objective of this study is to test the safety and effectiveness of DS-8201a for participants with HER2-expressing advanced colorectal cancer.

  8. Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients - Mayo Clinic

    To determine the effects of 12 weeks administration of different dose levels of ALV003 on the mucosal lining of the small intestine and symptoms in celiac ...

  9. Carboplatin and Gemcitabine Hydrochloride With or Without VX-970 in Treating Patients With Recurrent and Metastatic Ovarian, Primary Peritoneal, or Fallopian Tube Cancer - Mayo Clinic

    ATR kinase inhibitor VX-970 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving carboplatin and gemcitabine with ...

  10. News - Biology of Aging and Age-Related Diseases Laboratory - Mayo Clinic Research

    Research in Dr. Jurk's Biology of Aging and Age-Related Diseases Lab is currently examining how senescence contributes to various diseases related to aging.